About: MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $14.20 (+6.05%)
MDWD NASDAQ Mediwound Ltd
Mediwound Ltd share price
MDWD price activity
Last Price
$14.200
Change (24hr)
0.81 USD (6.05%)
Volume
329.12K
Volume (4w avg)
-
Open
$13.05
Day Range
$12.74 - $14.32
Previous Close
$13.39
Last Trade
04 Nov, 9:00 pm GMT+0
Delayed
04 Nov, 9:00 pm GMT+0
MDWD price performance
Delayed
04 Nov, 9:00 pm GMT+0
MDWD details
MDWD Market Signals